Thursday, October 29, 2026

Why Hanmi Pharmaceutical’s Pyeongtaek Manufacturing Center Achieved Top Safety Rating Again in 2026?

Hanmi Pharmaceutical's Pyeongtaek manufacturing center received the highest P grade in a safety management assessment by the Ministry of Employment and Labor.

May CPI Surge: What It Means for U.S. Interest Rates and Asian Markets

Global markets brace for U.S. CPI report amid rising inflation from energy prices, with Fed rate hikes anticipated later this year.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

Ha Na Park

No posts to display

Top News

- Our Sponsors Ad -

Follow us